Contact Us | Endometriosis Diagnosis Testing | EndoSure Inc.

Get in touch

(443) 391-7500

info@endosure.com

CONTACT US

Contact us any time

Contact us any time

ENDOSURE, INC. offers the only non-invasive, 30-minute, highly accurate, Tier-1 diagnostic test with immediate results for endometriosis that not only fills the gap, but addresses the vacuum in this area of women’s health care.

The ENDOSURE TEST has regulatory approval and is currently available for use in the European Union Countries, UK, Canada, Gulf States, Israel, Mexico and Brazil. At this time, it is available in the USA for research use only and not clinical use. ENDOSURE, INC. was created predicated upon a new approach to support physicians in the diagnosis of endometriosis.

Please include your questions or comments on this form.

EndoSure, Inc

954 Ridgebrook Road

Sparks Glencoe, Maryland 21152 USA

443-391-7500

We are online

info@endosure.com

ABOUT US

ENDOSURE, INC. offers the only non-invasive, 30-minute, highly accurate diagnosis test for endometriosis with instant results that not only fills the gap, but addresses the vacuum in this area of women’s health care.*

© September 2026 ENDOSURE, INC. All rights reserved

site design by

Boston Web Partners

CONTACT INFORMATION

954 Ridgebrook Road
Sparks Glencoe, Maryland 21152

INVESTORS

Investor@endosure.com

EndoSure, Inc
53 Loveton Circle, Suite 203
Sparks Glencoe, Maryland 21152

info@endosure.com

1. Approximately 15-20 minutes of patient preparation time may be required prior to performing the test.

2. Mathias JR, Franklin R, Quast DC, Fraga N, Loftin CA, Yates L, Harrison V. Relation of endometriosis and neuromuscular disease of the gastrointestinal tract: new insights. Fertil Steril. 1998 Jul;70(1):81-8.

3. i. Noar M, Mathias J, Kolatkar A. Gastrointestinal Myoelectrical Activity (GIMA) Biomarker for Noninvasive Diagnosis of Endometriosis. J Clin Med. 2024 May 13;13(10):2866. doi: 10.3390/jcm13102866. PMID: 38792407; PMCID: PMC11122642.

4. Zondervan, K.T.; Becker, C.M.; Koga, K.; Missmer, S.A.; Taylor, R.N.; Viganò, P. Endometriosis. Nat. Rev. Dis. Primers. 2018:4-9.

5. 1. Noar M, Mathias J, Kolatkar A. Validation of New GIMA Biomarker Signature of Endometriosis - Interim Data: Research Article. TechRxiv. August 26, 2024. DOI: 10.22541/au.172469630.08159498/v1

6. 1. Kitsantas P, Benson KN, Al-Farauki S, Knecht MK, Hennekens CH, et al. (2024) Emerging Diagnostic Tools for the Early Diagnosis of Endometriosis. J Reprod Med Gynecol Obstet 9: 171.

DISCLAIMER: THE ENDOSURE TEST IS A DIAGNOSTIC TOOL INTENDED TO INFORM AND ENHANCE A HEALTHCARE PROVIDER'S DECISION-MAKING PROCESS, WHICH IS INDIVIDUALIZED FOR EACH PATIENT'S CIRCUMSTANCES AND TAKE INTO ACCOUNT THE FULL SCOPE OF MEDICAL DATA AND INFORMATION AVAILABLE TO THE PROVIDER. THE ENDOSURE TEST IS NOT INTENDED TO SUBSTITUTE, REPLACE, OVERRULE, OR DIRECT A HEALTHCARE PROVIDER’S JUDGMENT.

443-391-7500

* USA CUSTOMERS: EndoSure is currently available for research in the USA use only and not clinical use.

Privacy Policy | Terms of Use

Share by: